![J. Christopher Prue](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
J. Christopher Prue
No más puestos en curso
Perfil
J.
Christopher Prue worked as a Senior Director-Regulatory Affairs at Rani Therapeutics Holdings, Inc. from 2021 to 2023.
Prior to that, he held positions as a Principal at The Upjohn Co., Incara Pharmaceuticals Corp., and Purdue Pharma LP.
He also served as the VP-Regulatory Affairs & Quality Assurance at BioDelivery Sciences International, Inc., Vice President-Regulatory Affairs at AtheroGenics, Inc., Flexion Therapeutics, Inc., and ABIONYX Pharma SA. Mr. Prue completed his undergraduate degree at Purdue University and obtained an MBA from Western Michigan University.
Antiguos cargos conocidos de J. Christopher Prue.
| Empresas | Cargo | Fin |
|---|---|---|
| RANI THERAPEUTICS HOLDINGS, INC. | Consejero General | 01/09/2023 |
AtheroGenics, Inc.
 AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Consejero General | 14/07/2009 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Consejero General | - |
| FLEXION THERAPEUTICS, INC. | Consejero General | - |
The Upjohn Co.
 The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Corporate Officer/Principal | - |
Formación de J. Christopher Prue.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
7
Relaciones de 1er grado
10
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 10 |
|---|---|
The Upjohn Co.
The Upjohn Co. Pharmaceuticals: MajorHealth Technology Manufacturer of pharmaceuticals | Health Technology |
Incara Pharmaceuticals Corp.
 Incara Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cardiovascular and pulmonary diseases | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of patients with musculoskeletal conditions | Health Technology |
Purdue Pharma LP
 Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Distribution Services |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Michigan University
 Western Michigan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ABIONYX Pharma SA
 ABIONYX Pharma SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel HDL therapies for the treatment of cardiovascular and metabolic diseases | Health Technology |
Rani Therapeutics Holdings, Inc.
 Rani Therapeutics Holdings, Inc. BiotechnologyHealth Technology Engages in research and development of orally administered biological products | Health Technology |
- Bolsa de valores
- Insiders
- J. Christopher Prue
